2009-11-10 13:01:02 - PolyNovo Biomaterials Pty Ltd - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/polynovo-bio ..

PolyNovo Biomaterials Pty Ltd - Medical Equipment - Deals and Alliances Profile

Summary

PolyNovo Biomaterials Pty Ltd (PolyNovo) is engaged in the research, design and manufacture of biodegradable polymers technology. It is a wholly-owned subsidiary of Xceed Biotechnology, Ltd. Its product line includes NovoSorb, a bioresorbable medical product used for the treatment of diseases and injuries. Its range of products includes stents, orthopaedics, drug delivery coatings, nerve regeneration and cartilage repair. The company is headquartered in Clayton South, Australia. In 2008, the company had an exclusive licensing agreement with Smith and Nephew, Inc.

The PolyNovo Biomaterials Pty Ltd - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business

 

 

structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.